Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning
暂无分享,去创建一个
Z. Nagy | F. Sinigaglia | E. Bono | F. Gallazzi | J. Hammer | C. Belunis | E Bono | F Gallazzi | F Sinigaglia | J Hammer | C Belunis | Z Nagy
[1] D. Wiley,et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.
[2] William Arbuthnot Sir Lane,et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.
[3] F. Sinigaglia,et al. Selection of T cell epitopes and vaccine engineering. , 1991, Methods in enzymology.
[4] F. Sinigaglia,et al. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries , 1992, The Journal of experimental medicine.
[5] J L Cornette,et al. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. , 1987, Journal of immunology.
[6] J. Rothbard,et al. Conformational and structural characteristics of peptides binding to HLA-DR molecules. , 1991, Journal of immunology.
[7] J. Woody,et al. Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin , 1982, Nature.
[8] M F del Guercio,et al. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. , 1993, Journal of immunology.
[9] Don C. Wiley,et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.
[10] H. Grey,et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Todd,et al. A molecular basis for MHC class II--associated autoimmunity. , 1988, Science.
[12] D. Wiley,et al. Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. , 1990, The EMBO journal.
[13] M. Davis,et al. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). , 1994, Journal of immunology.
[14] L. Kappos,et al. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. , 1993, The Journal of clinical investigation.
[15] F. Sinigaglia,et al. Promiscuous and allele-specific anchors in HLA-DR-binding peptides , 1993, Cell.
[16] H. Erlich,et al. MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.
[17] Eric O Long,et al. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis , 1991, The Journal of experimental medicine.
[18] Ronald N. Germain,et al. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.
[19] W. Taylor,et al. A sequence pattern common to T cell epitopes. , 1988, The EMBO journal.